Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites

被引:19
作者
Bert, F
Noussair, L
Lambert-Zechovsky, N
Valla, D
机构
[1] Hop Beaujon, Microbiol Serv, F-92110 Clichy, France
[2] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France
关键词
fluoroquinolones; prophylaxis; spontaneous bacterial peritonitis; viridans group streptococci;
D O I
10.1097/00042737-200509000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives The objective of the study was to examine the characteristics of spontaneous bacterial peritonitis (SBP) caused by streptococci, in particular viridans group streptococci (VGS), and to investigate a potential association between the long-term administration of norfloxacin and high-level resistance to fluoroquinolones in these organisms. Methods We reviewed 84 episodes of SBP and bacterascites caused by streptococci that occurred in 75 patients over a 6-year period. Isolates were tested for antibiotic susceptibility by the determination of minimum inhibitory concentrations. Results Of the 84 isolates, 46 (54.8%) were associated with SBR 12 (14.3%) were associated with symptomatic bacterascites, and 26 (31%) were associated with asymptomatic bacterascites. VGS were responsible for 39 of the 58 episodes of SBP and symptomatic bacterascites, largely preceding group B streptococci (n = 7), Streptococcus pneumoniae (n = 6) and Streptococcus bovis (n = 5). Most of the episodes were community acquired. An extraperitoneal site of infection was found in three patients only. Positive blood cultures were less frequent in patients with VGS infection than in those with SBP caused by other streptococci (12.8 versus 52.6%, P < 0.001). The rates of susceptibility to penicillin, amoxicillin and cefotaxime were 84.5, 879 and 91.4%, respectively. All isolates, including those from patients receiving norfloxacin, were susceptible to levofloxacin and moxifloxacin. Conclusions VGS are an underestimated cause of SBP in patients with cirrhosis. Most isolates are susceptible to P-lactam agents and new fluoroquinolones.
引用
收藏
页码:929 / 933
页数:5
相关论文
共 32 条
  • [1] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS - A REVIEW
    BOCHUD, PY
    CALANDRA, T
    FRANCIOLI, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1994, 97 (03) : 256 - 264
  • [2] Brook Itzhak, 2003, J Clin Pediatr Dent, V28, P13
  • [3] Pneumococcal peritonitis in adult patients -: Report of 64 cases with special reference to emergence of antibiotic resistance
    Capdevila, O
    Pallares, R
    Grau, I
    Tubau, F
    Liñares, J
    Ariza, J
    Gudiol, F
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) : 1742 - 1748
  • [4] PREVALENCE AND PROGNOSTIC-SIGNIFICANCE OF BACTERASCITES IN CIRRHOSIS WITH ASCITES
    CHU, CM
    CHANG, KY
    LIAW, YF
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (03) : 561 - 565
  • [5] *COM ANT SOC FRANC, COMMUNIQUE 2004
  • [6] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson, R
    Cavalcanti, R
    Brunton, JL
    Bast, DJ
    de Azavedo, JCS
    Kibsey, P
    Fleming, C
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 747 - 750
  • [7] de Luis D, 1997, An Med Interna, V14, P429
  • [8] Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States
    Doern, GV
    Ferraro, MJ
    Brueggemann, AB
    Ruoff, KL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 891 - 894
  • [9] IDENTITY OF VIRIDANS STREPTOCOCCI ISOLATED FROM CASES OF INFECTIVE ENDOCARDITIS
    DOUGLAS, CWI
    HEATH, J
    HAMPTON, KK
    PRESTON, FE
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1993, 39 (03) : 179 - 182
  • [10] Bacterial infections in cirrhosis:: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
    Fernández, J
    Navasa, M
    Gómez, J
    Colmenero, J
    Vila, J
    Arroyo, V
    Rodés, J
    [J]. HEPATOLOGY, 2002, 35 (01) : 140 - 148